Cargando…

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease

BACKGROUND: We investigated whether combinations of serum cytokines, used with logistic disease predictor models, could facilitate the detection of pancreatic ductal adenocarcinoma (PDAC). METHODS: The serum levels of 27 cytokines were measured in 241 subjects, 127 with PDAC, 49 with chronic pancrea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaw, Victoria E, Lane, Brian, Jenkinson, Claire, Cox, Trevor, Greenhalf, William, Halloran, Christopher M, Tang, Joseph, Sutton, Robert, Neoptolemos, John P, Costello, Eithne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032456/ https://www.ncbi.nlm.nih.gov/pubmed/24884871 http://dx.doi.org/10.1186/1476-4598-13-114

Ejemplares similares

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
por: Middleton, Gary, et al.
Publicado: (2016)

iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance
por: Tonack, S, et al.
Publicado: (2013)

The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
por: Kleeff, Jörg, et al.
Publicado: (2016)

Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue
por: Bauer, Andrea S., et al.
Publicado: (2012)

S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes
por: Nedjadi, Taoufik, et al.
Publicado: (2018)

Linking COVID-19 and Acute Pancreatitis Through the Pathogenic Effects of the SARS-CoV-2 S Protein Subunit 1 on Pancreatic Stellate Cells and Macrophages
por: Neoptolemos, J P, et al.
Publicado: (2022)

Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
por: Ferguson, Robert, et al.
Publicado: (2023)

Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes
por: Oldfield, Lucy, et al.
Publicado: (2022)

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
por: Martinelli, Paola, et al.
Publicado: (2017)

The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements
por: Ashworth, Milton, et al.
Publicado: (2021)

Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker
por: Martinez-Bosch, Neus, et al.
Publicado: (2018)

Recent advances in understanding pancreatic cancer
por: Stott, Martyn C, et al.
Publicado: (2022)

cAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: Effects of PKA and EPAC()
por: Burdyga, Alex, et al.
Publicado: (2013)

Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer
por: Bauer, Andrea S., et al.
Publicado: (2017)

Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival
por: Rachakonda, P. Sivaramakrishna, et al.
Publicado: (2013)

Pancreatic Cancer Susceptibility Loci and Their Role in Survival
por: Rizzato, Cosmeri, et al.
Publicado: (2011)

Natural history of SPINK1 germline mutation related-pancreatitis
por: Muller, Nelly, et al.
Publicado: (2019)

Where the metabolome meets the microbiome for pancreatic cancer detection
por: Oldfield, Lucy, et al.
Publicado: (2023)

A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study
por: Debernardi, Silvana, et al.
Publicado: (2020)

Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning
por: Nené, Nuno R., et al.
Publicado: (2023)

Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel
por: Nissinen, Samuli I., et al.
Publicado: (2022)

UHRF1 regulation of the Keap1–Nrf2 pathway in pancreatic cancer contributes to oncogenesis
por: Abu‐Alainin, Wafa, et al.
Publicado: (2015)

The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion
por: Evans, Anthony, et al.
Publicado: (2012)

What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses
por: Sultana, Asma, et al.
Publicado: (2015)

Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma
por: Ghassem-Zadeh, Sahar, et al.
Publicado: (2017)

Palladin Mutation Causes Familial Pancreatic Cancer: Absence in European Families
por: Slater, Emily, et al.
Publicado: (2007)

Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer
por: Mahajan, Ujjwal M, et al.
Publicado: (2019)

Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
por: Dive, C, et al.
Publicado: (2010)

Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
por: Lister, Adam, et al.
Publicado: (2011)

Severe acute pancreatitis: surgical indications and treatment
por: Heckler, Max, et al.
Publicado: (2020)

United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer
por: Oldfield, Lucy, et al.
Publicado: (2022)

hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
por: Aughton, Karen, et al.
Publicado: (2021)

The Value of Routine Biochemical Tests in Discriminating Between Malignant and Benign Pancreatic Tumours
por: Athlin, L., et al.
Publicado: (1991)

Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination
por: Itoi, Takao, et al.
Publicado: (2017)

Single-Port Retroperitoneal Pancreatic Necrosectomy for the Treatment of Extrapancreatic Walled-Off Necrotic Collections
por: Saunders, Rebecca, et al.
Publicado: (2021)

Prognosis Relevance of Serum Cytokines in Pancreatic Cancer
por: Torres, Carolina, et al.
Publicado: (2015)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma
por: Firpo, Matthew A., et al.
Publicado: (2023)

Relationship Between Cholesterolosis and Pancreatitis
por: Neoptolemos, John P., et al.
Publicado: (1991)

Role of cytokines in the interplay between cancer cells and stroma-associated monocytes
por: Nedjadi, Taoufik, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cnmjj25qev3mkaff9pmoervu2b